Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...

This marks the latest recall-related issue for HeartMate in recent years. Last June, the FDA deemed another recall as serious ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse platform.

Kardium today announced one-year clinical trial results for its Globe PF pulsed field ablation (PFA) system for treating AFib ...

HeartBeam announced that it entered into a strategic collaboration with AccurKardia to enhance cardiac monitoring ...

SonoMotion announced that it received a $2.2 million NIH grant and successfully completed enrollment in a pivotal clinical ...

Olympus announced today that it appointed Bob White, former Medtronic EVP, as its new CEO, effective June 1, 2025.

ClearPoint Neuro (Nasdaq:CLPT) announced that it kicked off the full-market launch of its latest navigation software.

The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium ...

LEM Surgical announced that it received FDA 510(k) clearance for its Dynamis robotic surgical system for hard tissue surgery.